About Pragya Pandey
Pragya is an equity research analyst and financial journalist with a passion for investing. In college she majored in finance and is currently pursuing the CFA program and is a Level II candidate.
When analyzing stocks, Pragya takes a fundamental approach and focuses on measuring a company's intrinsic value. Her goal is to help retail investors create successful portfolios to achieve financial success.
Recent Articles By Pragya Pandey
Is Shake Shack a Buy Despite Northcoast Downgrade?
Contemporary ‘roadside’ burger stand company Shake Shack (SHAK) has been striving to expand its services across the country and strengthen its market position. However, the stock dipped nearly 7.8% in price yesterday after Northcoast Research downgraded its rating. So, considering the company’s weak fundamentals and lofty valuations, is the stock worth owning now? Read more to find out.
Is Dogness a Good Pet Stock to Own?
China-based pet products manufacturer Dogness Corporation (DOGZ) has attracted significant investor attention due to its potential to benefit from the growing demand for pet-tech items that improve health and quality of life. But given the company’s poor profitability and inability to generate robust cash flow, is it worth betting on the stock now? Let's discuss.
Is EQONEX a Good Cryptocurrency Stock to Own?
Digital asset financial services company Eqonex Limited’s (EQOS) shares have generated significant momentum over the past month on the back of the company’s recent listing of Polkadot (DOT) token on its crypto trading platform. But will the stock be able to maintain its price rally amid rising competition in this space? Read more to find out.
After Beating Q3 Earnings Estimates, is Ontrak a Good Healthcare Stock to Buy?
AI-powered healthcare company Ontrak Inc. (OTRK) recently released its third-quarter earnings, which beat the consensus estimate. However, a lawsuit against the company and severe business headwinds may hinder its growth prospects. In addition, OTRK’s negative profit margin remains a concern. So, the question is, is it worth betting on the stock now? Let’s find out.
2 Top Value Stocks to Buy for the Long Haul
Investors’ renewed optimism regarding the economic recovery, and the consequent stock market momentum, has led to sky-high valuations for several stocks, which in some cases is not justified considering those names’ growth prospects. In addition, because the central bank has acknowledged that price increases have been more rapid and persistent than it anticipated, some investors could be spooked. So, we believe it could be wise to bet on quality stocks, such as Oracle Corporation (ORCL) and AstraZeneca Plc (AZN), which look undervalued at their current price levels. Read on.
Is Meten EdtechX Education Group a Buy Under $1?
Leading English language training provider Meten Holding Group’s (METX) stock has soared 54.5% in price over the past month thanks to the company’s strategic collaboration with AGM Group Holdings. However, given the company’s negative profit margins and mixed financials, can the stock continue rallying? Let’s discuss.
Beware of These 2 Meme Stocks in the Healthcare Industry
While subreddit r/WallStreetBets’ huge wagers against short sellers and the resulting short squeezes have helped several stocks skyrocket in price, many of those stocks have witnessed subsequent price declines on their fundamental weakness. Two cases in point are meme stocks in the healthcare space Clover Health Investments (CLOV) and Ocugen Inc. (OCGN). They look extremely risky, given their weak financials. So, we think they are best avoided now. Read on.
2 Monster Growth Stocks That Belong in Your Portfolio
The stock market is expected to experience significant volatility in the coming weeks as investors’ concern regarding the Fed’s upcoming decision on bond tapering and interest rate hikes remains. Thus, we think Silicon Motion Technology (SIMO) and Ryerson Holding (RYI), companies that possess exceptional growth features, could be ideal bets now. Read on.
Should You Buy the Dip in Zendesk?
Customer service software company Zendesk Inc. (ZEN) has been making efforts to expand its operations. However, investor skepticism over its $4 billion stock deal to takeover Momentive Global—and an ongoing investigation connected to the merger—are obscuring the company's growth prospects. In addition, given the company’s poor profitability and lofty valuations, there is a question as to whether the stock will be able to rebound from its recent price decline? Read ahead to learn more.